Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. M. Mannino, A. S. Brown, D. E. Doherty, A. S. Buist (Atlanta, Lexington, Portland, United States Of America). GOLD classification of COPD and subsequent mortality: findings from a cohort study. Eur Respir J 2004; 24: Suppl. 48, 4305

Member's Comments

No comment yet.

Related content which might interest you: GOLD classification of COPD and incident lung cancer: findings from a cohort study Source: Eur Respir J 2004; 24: Suppl. 48, 269s Year: 2004 GOLD classifications and mortality in COPD: The HUNT study Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 10-year cumulative incidence of COPD in a symptomatic cohort using BTS and GOLD spirometric criteria Source: Eur Respir J 2003; 22: Suppl. 45, 214s Year: 2003 The 2006 and 2011 GOLD classifications and five-years mortality in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Cluster analysis identifying patients with COPD at high-risk of 2-year mortality: preliminary results. Source: International Congress 2017 – Assessing the functional status of patients with COPD Year: 2017 Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 The impact of comorbidities on mortality in COPD, report from the OLIN COPD study. Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 The bronchitic phenotype is related to morbidity and mortality - report from the OLIN COPD study Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Implementation of the GOLD 2017 disease classification in a real-life COPD cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 External validation of the updated ADO score to predict mortality in COPD patients from the Birmingham COPD cohort Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 The OLIN COPD study – design and the first year‘s mortality Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006